Monselise M, Schwartz M, Politi F, Barishak Y R
Acta Ophthalmol (Copenh). 1984 Apr;62(2):315-9. doi: 10.1111/j.1755-3768.1984.tb08408.x.
The results of the combined use of Beta Irradiation, topical Thio-Tepa and dexamethasone in the post-operative treatment of pterygium in 169 patients (213 eyes) are reported. The recurrence rate has been evaluated statistically only in eyes with true pterygia, and for this purpose the material has been divided into 3 groups: group 1 includes all the bilateral cases who either had both eyes treated with Beta therapy or not, group 2 includes all the unilateral cases, and group 3 is made up of the total number of eyes operated. In the group comprising the bilateral cases, the recurrence rate was 2/60 in the eyes treated with Beta rays and 4/18 in the non-treated ones (P less than 0.10). In the group comprising the unilateral cases, the recurrence rate was 8/73 in the Beta rays treated eyes and 18/41 in the non-treated ones (P less than 0.025). When the total number of eyes was considered, the recurrence rate was 10/135 in the eyes treated with Beta rays and 22/61 in the non-treated ones (P less than 0.05). The difference in the recurrence rate between the eyes submitted to Beta therapy and those not submitted is considered statistically significant.
报告了对169例（213只眼）翼状胬肉患者术后联合使用β射线照射、局部使用噻替派和地塞米松的治疗结果。仅对真性翼状胬肉的眼睛进行了复发率的统计学评估，为此将资料分为3组：第1组包括所有双眼病例，无论双眼是否接受β射线治疗；第2组包括所有单眼病例；第3组由手术眼总数组成。在双眼病例组中，接受β射线治疗的眼睛复发率为2/60，未治疗的眼睛复发率为4/18（P＜0.10）。在单眼病例组中，接受β射线治疗的眼睛复发率为8/73，未治疗的眼睛复发率为18/41（P＜0.025）。当考虑手术眼总数时，接受β射线治疗的眼睛复发率为10/135，未治疗的眼睛复发率为22/61（P＜0.05）。接受β射线治疗的眼睛与未接受治疗的眼睛之间的复发率差异具有统计学意义。
